Wells Fargo Upgrades Voyager Therapeutics (VYGR) to Overweight
Tweet
Share
E-mailGet Alerts VYGR Hot Sheet
Price: $3.14 --0%
Rating Summary:
17 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 6 | New: 29
Rating Summary:
17 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 6 | New: 29
Join SI Premium – FREE
Wells Fargo analyst Jim Birchenough upgraded Voyager Therapeutics (NASDAQ: VYGR) from Equal Weight to Overweight with a price target of $14.00 (from $9.00).
For an analyst ratings summary and ratings history on Voyager Therapeutics click here. For more ratings news on Voyager Therapeutics click here.
Shares of Voyager Therapeutics closed at $8.44 yesterday.
You May Also Be Interested In
- Goldman Sachs Upgrades BNK Financial Group (138930:KS) to Buy
- Elemental Royalty Corp (ELE) PT Lowered to $31 at H.C. Wainwright
- UBS Upgrades L&T Financial Holdings (LTFH:IN) to Buy
Create E-mail Alert Related Categories
Analyst PT Change, UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
